Soil-transmitted helminthic vaccines: Where are we now?

Area of Science:

• Parasitology and Immunology
• Vaccine Development
• Tropical Medicine

Background:

• Soil-transmitted helminthic (STH) diseases affect millions globally, particularly in resource-limited settings, yet effective vaccines are lacking.
• Vaccine development for helminths faces significant hurdles, including complex life cycles, stage-specific antigens, and immune evasion strategies.

Approach:

• Systematic review utilizing qualitative meta-summary synthesis.
• Searched PubMed and Scopus for preclinical and clinical trials on protein subunit vaccines against Trichuris trichiura, Ascaris lumbricoides, Strongyloides stercoralis, Necator americanus, and Ancylostoma duodenale.
• Evaluated vaccine effectiveness based on reduction in worm burden/larval output, increased IgG levels, or enhanced cytokine production.

Key Points:

• Identification of effective vaccine candidates is a primary challenge in helminthic vaccine development.
• Only a vaccine targeting Necator americanus (hookworm) has reached the clinical trial phase.
• Vaccine candidates against other STHs (e.g., Trichuris trichiura, Ascaris lumbricoides) remain in preclinical and exploratory research stages.

Conclusions:

• Significant progress is needed to advance STH vaccine development beyond early research.
• Further research into helminth biology and immunology is crucial for identifying viable vaccine targets and strategies.
• The lack of approved STH vaccines highlights a critical gap in global infectious disease control efforts.